Business Context and Reporting Period
Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2000 (Third Quarter of Fiscal Year 2000)
Business Overview: The Company manufactures and distributes dietary supplements, vitamins, and herbal products. Operations include domestic facilities in California and a wholly-owned manufacturing subsidiary in Switzerland. The Company is currently executing a cost containment program and diversifying distribution channels following the loss of a major customer.
Key Financial Metrics
| Metric (in thousands) | Q3 2000 | Q3 1999 | 9 Months 2000 | 9 Months 1999 |
|---|---|---|---|---|
| Net Sales | $9,538 | $13,123 | $36,866 | $47,426 |
| Gross Profit | $596 | $1,891 | $2,954 | $9,810 |
| Gross Margin % | 6.3% | 14.4% | 8.0% | 20.7% |
| Net Loss | $(1,763) | $(4,321) | $(4,087) | $(2,418) |
| Loss Per Share (Diluted) | $(0.31) | $(0.73) | $(0.71) | $(0.41) |
| Cash and Equivalents | $1,000 | $2,683 | $1,000 | $2,683 |
| Total Debt (Outstanding) | $5,654 | $1,000 | $5,654 | $1,000 |
| Working Capital | $8,253 | $14,099 | $8,253 | $14,099 |
Note: Total Debt calculated as Current Installments of Long-Term Debt ($1,576) + Long-Term Debt ($4,079). Working Capital calculated as Total Current Assets ($19,518) - Total Current Liabilities ($11,265).
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 27.3% in Q3 2000 and 22.3% for the nine-month period compared to the prior year. This was primarily driven by the loss of Nu Skin Enterprises Inc., a major customer accounting for approximately 31% of Q3 1999 sales.
- Margin Compression: Gross margin dropped significantly to 6.3% in Q3 2000 from 14.4% in Q3 1999. Factors included reduced sales prices, lower production volume absorption of overhead, and increased quality control costs.
- Inventory Write-off: During the nine months ended March 31, 2000, the Company recorded a $2.0 million inventory write-off related to the loss of the major customer and declining market share.
- Debt Increase: Total outstanding debt increased from approximately $1.0 million at June 30, 1999, to $5.7 million at March 31, 2000. This increase funded capital expenditures for facility improvements and the Swiss subsidiary expansion.
- Lease Obligation: The Company accrued a $3.0 million liability for the loss on a lease obligation regarding an abandoned facility in Carlsbad, California, reclassified from long-term to current liabilities.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Cost Containment: The Company implemented a program reducing the workforce by approximately 27% in Q3 2000, with a further 25% reduction planned for May 2000. The goal is to align operating costs with current revenue levels.
- Strategic Initiatives: Management is focusing on diversifying sales through the Swiss manufacturing subsidiary, a joint venture with FitnessAge (Custom Nutrition), and a new direct-to-consumer brand ("Dr. Cherry").
- Facility Exit Strategy: The Company is negotiating to sublease or sell its leasehold interest in the abandoned Carlsbad facility to mitigate the $3.0 million lease liability.
- Profitability: Management expects to incur a net loss for the full fiscal year ending June 30, 2000, with no assurance of future profitability.
Risks and Contingencies
- Customer Concentration: For Q3 2000, two customers accounted for 81% of net sales. The loss of any major customer would have a material adverse impact.
- Legal Proceedings: The Company is defending a lawsuit filed by a former executive alleging damages in excess of $6 million. The Company has filed a cross-complaint seeking damages and injunctive relief.
- Debt Covenants: The Company was not in compliance with certain financial covenants of its line of credit as of March 31, 2000, though the lender has granted a waiver through June 30, 2000.
- Regulatory Environment: Operations are subject to FDA and FTC regulations regarding dietary supplements, which could lead to product recalls or reformulation requirements.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the top two customers, which represent 81% of Q3 revenue, and the risk of further concentration.
- Lease Liability Resolution: Monitor the progress of subleasing or selling the Carlsbad facility to determine if the $3.0 million accrued liability will be realized or reduced.
- Debt Covenant Compliance: Confirm the Company's ability to meet financial covenants after the waiver expires on June 30, 2000, and the status of loan renegotiations.
- Inventory Valuation: Assess the remaining inventory levels ($8.3 million) against current sales velocity to evaluate the risk of additional write-offs.
- Legal Exposure: Track the status of the $6 million lawsuit filed by the former executive and the Company's cross-complaint.